Bionano Genomics (BNGO) Preferred Stock Liabilities (2017)

Bionano Genomics (BNGO) reported Preferred Stock Liabilities of $842845.0 for Q4 2017.

Bionano Genomics (BNGO) Preferred Stock Liabilities (2017) Analysis & Trends

Bionano Genomics (BNGO) has 1 years of Preferred Stock Liabilities data on file, last reported at $842845.0 in Q4 2017.

For the quarter ending Q4 2017, Preferred Stock Liabilities changed N/A year-over-year to $842845.0; the trailing twelve-month figure through Dec 2017 stood at $842845.0 (changed N/A YoY), and the FY2017 full-year result was $842845.0, changed N/A from the prior year.
Preferred Stock Liabilities held at $842845.0 in Q4 2017.
In the past five years, Preferred Stock Liabilities ranged from a high of $842845.0 in Q4 2017 to a low of $842845.0 in Q4 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Stock Liabilities (Qtr)
1	Alcon	32,734,969.19 Bn	32,734,967.53 Bn	1.53 Bn	-
2	Intuitive Surgical	117.50 Bn	112.41 Bn	1.96 Bn	-
3	Becton Dickinson	42.93 Bn	42.11 Bn	2.15 Bn	-
4	Medline	30.82 Bn	36.66 Bn	1.84 Bn	-
5	Resmed	27.90 Bn	26.23 Bn	890.98 Mn	-
6	West Pharmaceutical Services	26.76 Bn	26.23 Bn	329.20 Mn	-
7	Cooper Companies	15.30 Bn	15.16 Bn	735.40 Mn	-
8	Solventum	13.46 Bn	12.90 Bn	1.10 Bn	-
9	Align Technology	12.02 Bn	10.96 Bn	736.59 Mn	-
10	Bionano Genomics	4.34 Mn	-9.35 Mn	3.25 Mn	-

Download Data

Date	Value
Dec 31, 2017	842,845.00